Operating Expenses Summary of Strides Pharma Science Limited

Strides Pharma Science Limited's latest annual operating expenses in 2023 was 9.16 Billion INR , down -48.06% from previous year.
Strides Pharma Science Limited's latest quarterly operating expenses in 2024 Q2 was 5.17 Billion INR , up 4.23% from previous quarter.
Strides Pharma Science Limited reported a annual operating expenses of 17.63 Billion INR in annual operating expenses 2022, up 4.97% from previous year.
Strides Pharma Science Limited reported a annual operating expenses of 16.8 Billion INR in annual operating expenses 2021, up 18.25% from previous year.
Strides Pharma Science Limited reported a quarterly operating expenses of 2.37 Billion INR for 2024 Q1, down -0.42% from previous quarter.
Strides Pharma Science Limited reported a quarterly operating expenses of 9.16 Billion INR for 2023 FY, down -48.06% from previous quarter.

Annual Operating Expenses Chart of Strides Pharma Science Limited (2023 - 2004)

Historical Annual Operating Expenses of Strides Pharma Science Limited (2023 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2023	9.16 Billion INR	-48.06%
2022	17.63 Billion INR	4.97%
2021	16.8 Billion INR	18.25%
2020	14.21 Billion INR	28.44%
2019	11.06 Billion INR	30.33%
2018	8.48 Billion INR	-24.46%
2017	11.23 Billion INR	28.58%
2016	8.74 Billion INR	-8.91%
2015	9.59 Billion INR	144.85%
2014	3.91 Billion INR	13.32%
2013	3.45 Billion INR	26.8%
2012	2.72 Billion INR	-67.2%
2011	8.31 Billion INR	69.88%
2010	4.89 Billion INR	26.51%
2009	3.86 Billion INR	322.09%
2008	916.65 Million INR	-64.75%
2007	2.6 Billion INR	3.58%
2006	2.51 Billion INR	32.38%
2005	1.89 Billion INR	38.69%
2004	1.36 Billion INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	5.17 Billion INR	4.23%
2024 Q1	2.37 Billion INR	-0.42%
2023 FY	9.16 Billion INR	-48.06%
2023 Q3	4.73 Billion INR	-2.96%
2023 Q2	4.88 Billion INR	11.48%
2023 Q4	2.38 Billion INR	-49.58%
2023 Q1	4.38 Billion INR	15.14%
2022 Q3	4.41 Billion INR	-6.83%
2022 Q4	3.8 Billion INR	-13.78%
2022 Q1	4.68 Billion INR	43.35%
2022 FY	17.63 Billion INR	4.97%
2022 Q2	4.73 Billion INR	1.04%
2021 Q3	4.52 Billion INR	-0.39%
2021 Q1	4.49 Billion INR	55.98%
2021 Q2	4.54 Billion INR	1.09%
2021 Q4	3.26 Billion INR	-27.77%
2021 FY	16.8 Billion INR	18.25%
2020 Q3	3.74 Billion INR	-1.61%
2020 FY	14.21 Billion INR	28.44%
2020 Q2	3.8 Billion INR	0.8%
2020 Q4	2.88 Billion INR	-23.05%
2020 Q1	3.77 Billion INR	120.07%
2019 Q2	3.11 Billion INR	7.74%
2019 Q4	1.71 Billion INR	-48.62%
2019 Q1	2.89 Billion INR	37.93%
2019 FY	11.06 Billion INR	30.33%
2019 Q3	3.33 Billion INR	7.18%
2018 Q3	2.45 Billion INR	1.27%
2018 FY	8.48 Billion INR	-24.46%
2018 Q4	2.09 Billion INR	-14.55%
2018 Q2	2.42 Billion INR	19.82%
2018 Q1	2.02 Billion INR	-38.56%
2017 Q2	3.11 Billion INR	15.46%
2017 Q3	3.06 Billion INR	-1.69%
2017 Q4	3.29 Billion INR	7.33%
2017 Q1	2.7 Billion INR	-7.98%
2017 FY	11.23 Billion INR	28.58%
2016 Q2	3.88 Billion INR	18.91%
2016 FY	8.74 Billion INR	-8.91%
2016 Q3	2.74 Billion INR	-29.25%
2016 Q4	2.93 Billion INR	6.85%
2016 Q1	3.26 Billion INR	-12.48%
2015 FY	9.59 Billion INR	144.85%
2015 Q2	2.52 Billion INR	6.05%
2015 Q4	3.73 Billion INR	17.08%
2015 Q3	3.18 Billion INR	26.24%
2015 Q1	2.38 Billion INR	152.05%
2014 Q3	1.04 Billion INR	0.75%
2014 FY	3.91 Billion INR	13.32%
2014 Q2	1.03 Billion INR	28.9%
2014 Q1	804.99 Million INR	0.0%
2014 Q4	944.78 Million INR	-9.63%
2013 FY	3.45 Billion INR	26.8%
2012 FY	2.72 Billion INR	-67.2%
2011 FY	8.31 Billion INR	69.88%
2010 FY	4.89 Billion INR	26.51%
2009 FY	3.86 Billion INR	322.09%
2008 FY	916.65 Million INR	-64.75%
2007 FY	2.6 Billion INR	3.58%
2006 FY	2.51 Billion INR	32.38%
2005 FY	1.89 Billion INR	38.69%
2004 FY	1.36 Billion INR	0.0%

Peer Operating Expenses Comparison of Strides Pharma Science Limited

Name	Operating Expenses	Operating Expenses Difference
Alembic Pharmaceuticals Limited	15.86 Billion INR	42.265%
Aurobindo Pharma Limited	39.23 Billion INR	76.648%
Glenmark Life Sciences Limited	11.64 Billion INR	21.291%
Granules India Limited	7.18 Billion INR	-27.567%
Indoco Remedies Limited	4.74 Billion INR	-92.94%
Achyut Healthcare Limited	1.6 Million INR	-569340.646%
Ajanta Pharma Limited	30.46 Billion INR	69.923%
Alkem Laboratories Limited	32.83 Billion INR	72.096%
Alpa Laboratories Limited	156.14 Million INR	-5767.74%
Brooks Laboratories Limited	51.18 Million INR	-17802.11%
AstraZeneca Pharma India Limited	2.6 Billion INR	-252.342%
Bajaj HealthCare Limited	985.34 Million INR	-829.857%
Bliss GVS Pharma Limited	1.41 Billion INR	-545.586%
Dr. Reddy's Laboratories Limited	95.87 Billion INR	90.444%
Eris Lifesciences Limited	4.94 Billion INR	-85.361%
FDC Limited	5.34 Billion INR	-71.305%
Glenmark Pharmaceuticals Limited	67.56 Billion INR	86.439%
Gufic Biosciences Limited	1.07 Billion INR	-750.163%
Ind-Swift Laboratories Limited	2.12 Billion INR	-331.333%
Ipca Laboratories Limited	13.91 Billion INR	34.155%
Jagsonpal Pharmaceuticals Limited	773.41 Million INR	-1084.663%
Krebs Biochemicals & Industries Limited	46.15 Million INR	-19750.724%
Lasa Supergenerics Limited	291.17 Million INR	-3046.675%
Laurus Labs Limited	3.01 Billion INR	-204.314%
Lupin Limited	95.67 Billion INR	90.423%
Mankind Pharma Limited	23.15 Billion INR	60.427%
Medicamen Biotech Limited	335.16 Million INR	-2633.652%
Medico Remedies Limited	161.84 Million INR	-5561.192%
Megasoft Limited	49.52 Million INR	-18399.233%
NATCO Pharma Limited	10.05 Billion INR	8.905%
Piramal Pharma Limited	19.91 Billion INR	53.991%
RPG Life Sciences Limited	1.63 Billion INR	-460.214%
Sigachi Industries Limited	579.88 Million INR	-1480.015%
Sun Pharmaceutical Industries Limited	154.18 Billion INR	94.057%
Suven Pharmaceuticals Limited	1.4 Billion INR	-553.149%
Syncom Formulations (India) Limited	942.39 Million INR	-872.232%
Unichem Laboratories Limited	6.72 Billion INR	-36.225%
Wanbury Limited	1.16 Billion INR	-689.223%
Windlas Biotech Limited	1 Billion INR	-810.304%
ZIM Laboratories Limited	1.01 Billion INR	-804.42%
Zydus Lifesciences Limited	43.17 Billion INR	78.778%
Sun Pharma Advanced Research Company Limited	3.07 Billion INR	-197.787%
Divi's Laboratories Limited	14.17 Billion INR	35.34%
Hester Biosciences Limited	908.84 Million INR	-908.131%
Procter & Gamble Health Limited	2.99 Billion INR	-205.879%
Amrutanjan Health Care Limited	1.09 Billion INR	-733.703%
Bal Pharma Limited	389.89 Million INR	-2249.971%
Venus Remedies Limited	1.91 Billion INR	-378.129%
Aarti Pharmalabs Limited	3.07 Billion INR	-198.019%
Nectar Lifesciences Limited	625.55 Million INR	-1364.679%
Shilpa Medicare Limited	2.18 Billion INR	-320.175%
Aarti Drugs Limited	1.16 Billion INR	-684.794%
IOL Chemicals and Pharmaceuticals Limited	1.09 Billion INR	-733.846%
Suven Life Sciences Limited	109.75 Million INR	-8248.337%
Ind-Swift Limited	946.56 Million INR	-867.95%
Valiant Laboratories Limited	36.28 Million INR	-25148.147%
J. B. Chemicals & Pharmaceuticals Limited	8.41 Billion INR	-8.854%
Solara Active Pharma Sciences Limited	4.57 Billion INR	-100.063%
Themis Medicare Limited	782.85 Million INR	-1070.37%
Hikal Limited	2.48 Billion INR	-268.506%
Torrent Pharmaceuticals Limited	21.42 Billion INR	57.23%
Sequent Scientific Limited	2.9 Billion INR	-215.744%
Novartis India Limited	470.1 Million INR	-1849.011%
Wockhardt Limited	6.4 Billion INR	-43.161%
Jubilant Pharmova Limited	14.45 Billion INR	36.611%
Biofil Chemicals and Pharmaceuticals Limited	16.2 Million INR	-56423.567%
Neuland Laboratories Limited	2.92 Billion INR	-212.734%
Morepen Laboratories Limited	1.98 Billion INR	-361.008%
Kilitch Drugs (India) Limited	412.42 Million INR	-2121.557%
Mangalam Drugs & Organics Limited	676.14 Million INR	-1255.075%

Global Stocks Search

Strides Pharma Science Limited (STAR.BO)

Operating Expenses Summary of Strides Pharma Science Limited

Annual Operating Expenses Chart of Strides Pharma Science Limited (2023 - 2004)

Historical Annual Operating Expenses of Strides Pharma Science Limited (2023 - 2004)

Peer Operating Expenses Comparison of Strides Pharma Science Limited